Prognostic significance and molecular associations of CDKN2A (p16) promoter methylation and loss of expression in colorectal cancer

被引：0
|
作者：
Shima, Kaori
Nosho, Katsuhiko
Baba, Yoshifumi
Cantor, Mami
Giovannucci, Edward L.
Fuchs, Charles S.
Ogino, Shuji
机构：
来源：
CANCER RESEARCH | 2010年 / 70卷
关键词：
D O I：
10.1158/1538-7445.AM10-4639
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4639
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Prognostic significance and molecular associations of CDKN2A (p16) promoter methylation and loss of expression in colorectal cancer
    Shima, Kaori
    Nosho, Katsuhiko
    Baba, Yoshifumi
    Cantor, Mami
    Giovannucci, Edward L.
    Fuchs, Charles S.
    Ogino, Shuji
    CANCER RESEARCH, 2010, 70
  • [2] Prognostic significance of CDKN2A (p16) promoter methylation and loss of expression in 902 colorectal cancers: cohort study and literature review
    Shima, Kaori
    Nosho, Katsuhiko
    Baba, Yoshifumi
    Cantor, Mami
    Meyerhardt, Jeffrey A.
    Giovannucci, Edward L.
    Fuchs, Charles S.
    Ogino, Shuji
    INTERNATIONAL JOURNAL OF CANCER, 2011, 128 (05) : 1080 - 1094
  • [3] Prognostic significance of p16/cdkn2a loss in pleural malignant mesotheliomas
    Dacic, Sanja
    Kothmaier, Hannelore
    Land, Stephanie
    Shuai, Yongli
    Halbwedl, Iris
    Morbini, Patrizia
    Murer, Bruno
    Comin, Camilla
    Galateau-Salle, Francoise
    Demirag, Funda
    Zeren, Handan
    Attanoos, Richard
    Gibbs, Alan
    Cagle, Philip
    Popper, Helmut
    VIRCHOWS ARCHIV, 2008, 453 (06) : 627 - 635
  • [4] Prognostic significance of p16/cdkn2a loss in pleural malignant mesotheliomas
    Sanja Dacic
    Hannelore Kothmaier
    Stephanie Land
    Yongli Shuai
    Iris Halbwedl
    Patrizia Morbini
    Bruno Murer
    Camilla Comin
    Françoise Galateau-Salle
    Funda Demirag
    Handan Zeren
    Richard Attanoos
    Alan Gibbs
    Philip Cagle
    Helmut Popper
    Virchows Archiv, 2008, 453 : 627 - 635
  • [5] Promoter methylation of CDKN2A and lack of p16 expression characterize patients with hepatocellular carcinoma
    Csepregi, Antal
    Ebert, Matthias P. A.
    Roecken, Christoph
    Schneider-Stock, Regine
    Hoffmann, Juliane
    Schulz, Hans-Ulrich
    Roessner, Albert
    Malfertheiner, Peter
    BMC CANCER, 2010, 10
  • [6] Promoter methylation of CDKN2A and lack of p16 expression characterize patients with hepatocellular carcinoma
    Antal Csepregi
    Matthias PA Ebert
    Christoph Röcken
    Regine Schneider-Stock
    Juliane Hoffmann
    Hans-Ulrich Schulz
    Albert Roessner
    Peter Malfertheiner
    BMC Cancer, 10
  • [7] Prognostic significance of p16/CDKN2A deletion in pleural mesotheliomas
    Dacic, S.
    Popper, H. H.
    Kothmaier, H.
    Halbwedl, I.
    Morbini, P.
    Murer, B.
    Comin, C. E.
    Galateau-Salle, F.
    Demirag, F.
    Zeren, H.
    Attanoos, R.
    Gibbs, A.
    Cagle, P. T.
    LABORATORY INVESTIGATION, 2008, 88 : 339A - 340A
  • [8] Prognostic significance of p16/CDKN2A deletion in pleural mesotheliomas
    Dacic, S.
    Poppei, H. H.
    Kothmaier, H.
    Halbwedt, I.
    Morbini, P.
    Murer, B.
    Comin, C. E.
    Galateau-Salle, F.
    Demirag, F.
    Zeren, H.
    Allanoos, R.
    Gibbs, A.
    Cagle, P. T.
    MODERN PATHOLOGY, 2008, 21 : 339A - 340A
  • [9] Promoter methylation status of hMLH1, MGMT, and CDKN2A/p16 in colorectal adenomas
    Psofaki, Vasiliki
    Kalogera, Chryssoula
    Tzambouras, Nikolaos
    Stephanou, Dimitrios
    Tsianos, Epameinondas
    Seferiadis, Konstantin
    Kolios, Georgios
    WORLD JOURNAL OF GASTROENTEROLOGY, 2010, 16 (28) : 3553 - 3560
  • [10] Promoter methylation status of hMLH1,MGMT,and CDKN2A/p16 in colorectal adenomas
    Vasiliki Psofaki
    Chryssoula Kalogera
    Nikolaos Tzambouras
    Dimitrios Stephanou
    Epameinondas Tsianos
    Konstantin Seferiadis
    Georgios Kolios
    World Journal of Gastroenterology, 2010, 16 (28) : 3553 - 3560
12345